Mislabeled insulin syringes manufactured by Covidien. Ltd. and sold by Wal-Mart and Sam's Club stores have been recalled, according to a report in the New York Times, "Insulin Syringes Are Recalled." The recall was announced by the Food and Drug Administration. The mislabeling could cause patients to receive 2.5 times the normal dose; approximately 471,000 syringes, which go by the brand name ReliOn, are said to affected.
Post a comment
Your Information
(Name and email address are required. Email address will not be displayed with the comment.)
Comments